News Novartis Launches Review Into Safety of Eye Drug Beovu by Medscape • 2020/02/25 • 0 Comments Novartis has launched an external review into the safety of its blindness medicine Beovu after the American Society of Retinal Specialists (ASRS) raised concerns. Reuters Health Information Full Story →